Dr Moses is a Neurologist and Fellow of Royal Australasian College of Physicians. He is a senior neurology and neurophysiology consultant at Monash Medical Centre having previously held a VMO position at St Vincent's Public Hospital (2008 - 2015). 

 

Dr Moses was a clinical and neurophysiology fellow at St Vincent's Hospital, Melbourne (2003 - 2007). He was admitted to Fellowship of RACP in 2007 after passing the RACP part I and II exams. Prior to that Dr Moses completed a formal Neurology training program at Rambam Medical Centre, Israel 1994 - 2001 and was registered as Specialist Neurologist after passing Neurology Board exams. Dr Moses received his medical degree from Tbilisi State Medical University.

 

Dr Moses actively participates in RACP-accredited CME program. He is a full member of the Australian and New Zealand Association of Neurologists and American Association of Neuromuscular & Electrodiagnostic Medicine. He participates in undergraduate and postgraduate teaching and registrar's training.

 

Research included fellowships at Prof John Finberg's lab, Neuropharmacology, Technion, Israel focusing on Rasagiline and with Prof Mal Horne and Prof John Drago at Howard Florey Institute, Melbourne University working on the novel therapies for Parkinson's Disease. He authored a number of peer-reviewed publications and together with A/Prof Ian Trounce and A/Prof Zane Andrews was the recipient of The Michael J Fox for Parkinson's disease foundation grant (link). 

Selected publications in peer-reviewed journals:

 

Frugier T, Conquest A, McLean C, Currie P, Moses D, Goldshmit Y. Expression and activation of EphA4 in the human brain after traumatic injury. J Neuropathol Exp Neurol. 2012 Mar;71(3):242-50.

 

Plummer C, Vogrin S, Cook M, Moses D. Curing of oscillating larynx by levetiracetam. Arch Neurol. 2011 Aug;68(8):1075

Fernando, CV, Moses, D, Parish CL, Thomas D, Drago, J, Horne, M. K., Creating a Ventral Midbrain Stem Cell Niche in an Animal Model for Parkinson's Disease. Stem Cells Dev, 2010 Apr 23 

George JL, Mok S, Moses D, Wilkins S, Bush AI, Cherny RA, Finkelstein DI, Targeting the progression of Parkinson's disease. Curr Neuropharmacol. 2009 Mar;7(1):9-36

Moses, D, Drago, J, Teper, Y, Gantois, I., Finkelstein, D. I., Horne, M. K., Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo. Neuroscience, Available online 8 April 2008

Nisbet DR, Moses D, Gengenbach TR, Forsythe JS, Finkelstein DI, Horne MK., Enhancing neurite outgrowth from primary neurones and neural stem cells using thermoresponsive hydrogel scaffolds for the repair of spinal cord injury.J Biomed Mater Res A. 2008 Apr 10; [Epub ahead of print] PMID: 18404707 [PubMed – as supplied by publisher]

 

 

Moses, D, Teper, Y., Gantois, I., Finkelstein, D. I., Horne, M. K., and Drago, J. 2006. Murine embryonic EGF-responsive ventral mesencephalic neurospheres display distinct regional specification and promote survival of dopaminergic neurons. Exp Neurol 199: 209-221.

 

 

Moses D, Gross A, Finberg J.P.M. 2004 Rasagiline enhances LDOPA-induced contralateral turning in the unilateral 6-hydroxydopamine-lesioned guinea pig. Neuropharmacology.Jul;47(1):72-80.

Ph:  9005 7275 or 9578 2145

All correspondence to: PO Box 312, Ormond 3204

© 2017